B. Olivero

PCR-Based Minimal Residual Disease (MRD) Detection Is a Strong Independent Outcome Predictor Also in Rituximab-Intensive Non-ASCT-Based Programs: Results From the ML17638 Multicenter Randomised Phase III Trial for Elderly Follicular Lymphoma (FL) Patients of the Fondazione Italiana Linfomi (FIL)

R. Fanin, S. Sacchi, L. Baldini, 2012 .

Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B‐cell nonfollicular lymphomas

L. Baldini, F. Merli, A. Ferrario, 2012, Cancer.

Unilateral exophthalmos and multiple subcutaneous nodules as a result of extranodal marginal zone lymphoma.

L. Baldini, A. Ferrario, M. Goldaniga, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide for Initial Treatment of Elderly Multiple Myeloma Patients.

M. Boccadoro, D. Rossi, G. Gaidano, 2009 .

Front-Line Chemo-Immunotherapy Rituximab-FC + Rituximab Maintenance in Patients with Untreated Advanced Stage Non Follicular Lymphoma (INFL): Preliminary Results of a Prospective Study of the Intergruppo Italiano Linfomi and Roche (ML18324).

L. Baldini, F. Merli, G. Rossi, 2008 .

Use of fresh-frozen plasma in 2012 at the Fondazione Ca' Granda Hospital of Milan: assessment of appropriateness using record linkage techniques applied to data routinely recorded in various hospital information systems.

M. Marconi, S. Castaldi, E. Raspollini, 2018, Blood transfusion = Trasfusione del sangue.

Clinical effectiveness of platelets in additive solution treated with two commercial pathogen‐reduction technologies

M. Graf, N. Scarpato, M. Marconi, 2017, Transfusion.

Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant

D. Rossi, T. Guglielmelli, A. Citro, 2011, Leukemia & lymphoma.

A real‐life evaluation of two platelet cross‐matching programmes for the treatment of patients refractory to platelet transfusions

P. Rebulla, D. Prati, M. Marini, 2018, Vox sanguinis.